VPT.V Stock - VentriPoint Diagnostics Ltd.
Unlock GoAI Insights for VPT.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $95,172 | $49,183 | $68,167 | N/A | $36,017 |
| Gross Profit | $95,172 | $42,434 | $57,808 | $-48,812 | $26,270 |
| Gross Margin | 100.0% | 86.3% | 84.8% | N/A | 72.9% |
| Operating Income | $-4,801,816 | $-4,930,498 | $-4,910,725 | $-3,715,418 | $-1,889,097 |
| Net Income | $-4,919,573 | $-4,871,937 | $-4,872,800 | $-3,881,030 | $-1,850,676 |
| Net Margin | -5169.1% | -9905.7% | -7148.3% | N/A | -5138.3% |
| EPS | $-0.03 | $-0.03 | $-0.03 | $-0.03 | $-0.02 |
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
VPT.VEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q4 2025 | Nov 28, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 29, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 30, 2025 | — | $-0.01 | — | — |
Q2 2025 | Apr 29, 2025 | — | $-0.01 | — | — |
Q4 2024 | Nov 27, 2024 | — | $-0.01 | — | — |
Q3 2024 | Aug 29, 2024 | — | $-0.01 | — | — |
Q2 2024 | May 30, 2024 | — | $-0.01 | — | — |
Q2 2024 | Apr 29, 2024 | — | $-0.01 | — | — |
Q4 2023 | Nov 29, 2023 | — | $-0.01 | — | — |
Q3 2023 | Sep 6, 2023 | — | $-0.01 | — | — |
Q2 2023 | Jun 1, 2023 | — | $-0.01 | — | — |
Q2 2023 | May 4, 2023 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.01 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.01 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.01 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about VPT.V
What is VPT.V's current stock price?
What is the analyst price target for VPT.V?
What sector is VentriPoint Diagnostics Ltd. in?
What is VPT.V's market cap?
Does VPT.V pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VPT.V for comparison